Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Operating Expenses: 2024-2025

Historic Operating Expenses for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $100.7 million.

  • Kura Oncology's Operating Expenses rose 68.24% to $100.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $343.8 million, marking a year-over-year change of. This contributed to the annual value of $247.1 million for FY2024, which is 49.02% up from last year.
  • Latest data reveals that Kura Oncology reported Operating Expenses of $100.7 million as of Q3 2025, which was up 14.55% from $88.0 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Operating Expenses peaked at $100.7 million during Q3 2025, and registered a low of $54.5 million during Q1 2024.
  • In the last 2 years, Kura Oncology's Operating Expenses had a median value of $76.3 million in 2024 and averaged $73.5 million.
  • Data for Kura Oncology's Operating Expenses shows a peak YoY skyrocketed of 68.24% (in 2025) over the last 5 years.
  • Kura Oncology's Operating Expenses (Quarterly) stood at $76.3 million in 2024, then skyrocketed by 68.24% to $100.7 million in 2025.
  • Its Operating Expenses was $100.7 million in Q3 2025, compared to $88.0 million in Q2 2025 and $78.8 million in Q1 2025.